gmp-orphan SA ("GMPO"​)

📍 Paris, France🗓 Founded 2011👥 31 employees💰 Last funded May 2016
Pharmaceuticals🌐 gmp-o.com
Website LinkedIn
At gmp-orphan (GMPO), it is our mission to identify, develop and provide access to innovative treatments to patients with rare diseases. Our experienced pharmaceutical development and commercial team in the field of rare diseases is critical in advancing this mission. gmp-orphan (GMPO) was founded in 2011 and the company’s most advanced product candidate is Cuprior for the treatment of Wilson Disease.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2011
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
2
Frequently asked questions
Who invested in gmp-orphan SA ("GMPO"​)?
gmp-orphan SA ("GMPO"​) has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did gmp-orphan SA ("GMPO"​) last raise funding?
The most recent investment in gmp-orphan SA ("GMPO"​) recorded on gritt.io was in May 2016.
When was gmp-orphan SA ("GMPO"​) founded?
gmp-orphan SA ("GMPO"​) was founded in 2011.
What industry is gmp-orphan SA ("GMPO"​) in?
gmp-orphan SA ("GMPO"​) operates in Pharmaceuticals. Find similar Pharmaceuticals investors on gritt.io.
Where is gmp-orphan SA ("GMPO"​) based?
gmp-orphan SA ("GMPO"​) is headquartered in Paris, France.